Company intelligence / Profile preview

Neurogan

San Diego, California, USA

Ownership: Private
Development stage: Other

Overview

Neurogan markets high-potency, hemp-derived CBD and cannabinoid products, with anecdotal and customer-supported benefits reported for sleep, stress, and pain relief. Their offering includes oral drops, topicals, and gummies, each batch tested for potency and purity, but peer-reviewed clinical data are not available.

Therapeutic areas: NeurologyRheumatologyPsychiatryOther
Modalities: Small moleculeBiologic
Industry: Food & Nutrition

Partnerships

WR Group

Beyond the preview

Go deeper on Neurogan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurogan.

Explore the full profile